We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $1.12B
1-Year Est. Return 390.6%
This Fund
S&P 500
This Quarter Est. Return
+69.1%
1 Year Est. Return
+390.6%
3 Year Est. Return
+6,011.55%
5 Year Est. Return
+59,317.78%
10 Year Est. Return
+26,738,243.47%
AUM
$1.12B
AUM Growth
+$256M
Cap. Flow
-$65.8M
Cap. Flow %
-5.86%
Top 10 Hldgs %
12.62%
Holding
395
New
122
Increased
12
Reduced
133
Closed
127

Top Sells

Rank Stock Value
1
AEIS icon
Advanced Energy
AEIS
+$14.4M
2
LASR icon
nLIGHT
LASR
+$10.3M
3
AXTI icon
AXT Inc
AXTI
+$10.1M
4
NXT icon
Nextpower Inc. Common Stock
NXT
+$8.5M
5
GLNG icon
Golar LNG
GLNG
+$8.32M

Sector Composition

Rank Sector Weight
1 Technology 33.94%
2 Industrials 20.46%
3 Healthcare 17.37%
4 Financials 5.27%
5 Consumer Discretionary 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YOU icon
151
Clear Secure
YOU
$4.49B
$3.17M 0.28%
56,934
-15,310
-21% -$837K
FRO icon
152
Frontline
FRO
$10.4B
$3.11M 0.28%
89,464
-20,817
-19% -$765K
AXTI icon
153
AXT Inc
AXTI
$4.56B
$3.09M 0.28%
42,817
-112,194
-72% -$10.1M
VISN
154
Vistance Networks Inc
VISN
$1.49B
$3.08M 0.27%
240,985
-3,672
-2% -$51.8K
BW icon
155
Babcock & Wilcox
BW
$1.15B
$3.05M 0.27%
216,327
-259,159
-55% -$4.4M
FEIM icon
156
Frequency Electronics
FEIM
$730M
$2.98M 0.27%
44,871
-2,072
-4% -$128K
IRDM icon
157
Iridium Communications
IRDM
$5.07B
$2.92M 0.26%
+53,324
New +$2.28M
URGN icon
158
UroGen Pharma
URGN
$2.14B
$2.92M 0.26%
+79,271
New +$2.15M
XENE icon
159
Xenon Pharmaceuticals
XENE
$5.77B
$2.91M 0.26%
48,163
-18,387
-28% -$1.02M
EZPW icon
160
Ezcorp Inc
EZPW
$2.03B
$2.9M 0.26%
83,810
-90,187
-52% -$2.85M
PVLA
161
Palvella Therapeutics
PVLA
$2.19B
$2.88M 0.26%
18,849
-10,479
-36% -$1.27M
AAOI icon
162
Applied Optoelectronics
AAOI
$9.47B
$2.86M 0.25%
19,284
-19,881
-51% -$3.23M
SXT icon
163
Sensient Technologies
SXT
$5.7B
$2.83M 0.25%
+22,962
New +$2.55M
TKR icon
164
Timken Company
TKR
$8.58B
$2.65M 0.24%
18,265
-15,990
-47% -$1.92M
BAND
165
Bandwidth Inc
BAND
$1.4B
$2.64M 0.23%
+41,644
New +$1.87M
FCFS icon
166
FirstCash
FCFS
$9.78B
$2.62M 0.23%
12,120
-21,149
-64% -$4.59M
KYMR icon
167
Kymera Therapeutics
KYMR
$9.68B
$2.41M 0.22%
21,056
-21,285
-50% -$1.83M
ELA icon
168
Envela
ELA
$365M
$2.38M 0.21%
82,522
-14,644
-15% -$326K
OSS icon
169
One Stop Systems
OSS
$245M
$2.37M 0.21%
130,568
-5,421
-4% -$75.5K
INDV icon
170
Indivior Pharmaceuticals
INDV
$4.05B
$2.35M 0.21%
57,297
-884
-2% -$32.1K
AIR icon
171
AAR Corp
AIR
$5.26B
$2.26M 0.2%
15,835
-31,287
-66% -$3.69M
INBX icon
172
Inhibrx
INBX
$1.68B
$2.19M 0.19%
+23,077
New +$2.31M
AXGN icon
173
Axogen
AXGN
$2.51B
$2.07M 0.18%
44,907
-699
-2% -$28.2K
COGT icon
174
Cogent Biosciences
COGT
$6.12B
$2.06M 0.18%
53,129
-68,799
-56% -$2.41M
TXG icon
175
10x Genomics
TXG
$8.55B
$2M 0.18%
+52,232
New +$1.37M

Similar funds

EAM Investors's Q2 2026 Portfolio in Review

As of Q2 2026, EAM Investors held 395 positions worth $1.12B, up 30% from $866M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

EAM Investors withdrew a net $65.8M in Q2 2026, closing 127 positions and reducing 133 holdings. Its most notable exit was Advanced Energy, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, EAM Investors opened a new position in Ceco Environmental worth $11M.

  • EAM Investors's largest Q2 2026 buy was Ceco Environmental: 120,677 shares worth $11M.
  • EAM Investors added most to iShares MSCI India Small-Cap ETF in Q2 2026, an estimated $26.7M increase.
  • EAM Investors's biggest Q2 2026 reduction was nLIGHT, cutting an estimated $10.3M.
  • EAM Investors fully exited Advanced Energy in Q2 2026, selling an estimated $14.4M.
  • EAM Investors's ten largest holdings make up 13% of its $1.12B portfolio in Q2 2026.
  • EAM Investors opened 122 new positions and closed 127 in Q2 2026.
  • EAM Investors's portfolio value rose 30% quarter-over-quarter to $1.12B.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.